Clover Health Investments
CLOV
137 hedge funds and large institutions have $71.1M invested in Clover Health Investments in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 20 closing their positions.
67% more call options, than puts
Call options by funds: $2.22M | Put options by funds: $1.33M
11% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 35
2.26% less ownership
Funds ownership: 24.35% → 22.09% (-2.3%)
5% less funds holding
Funds holding: 144 → 137 (-7)
23% less capital invested
Capital invested by funds: $92.7M → $71.1M (-$21.6M)
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.81M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$1.25M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.19M |
| 4 |
D.E. Shaw & Co
New York
|
+$808K |
| 5 |
JP Morgan Chase
New York
|
+$675K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.04M |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.11M |
| 3 |
Renaissance Technologies
New York
|
-$1.08M |
| 4 |
Two Sigma Investments
New York
|
-$1.01M |
| 5 |
Two Sigma Advisers
New York
|
-$956K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ASN
151
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -1,053 | Closed |
|
|
LA
152
LM Advisors
San Diego,
California
| – | -$952 | -1,000 | Closed |
|
|
ODG
153
O'Dell Group
Cincinnati,
Ohio
| – | -$58 | -60 | Closed |
|
154
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$52 | -55 | Closed |
|
|
MSWM
155
McGlone Suttner Wealth Management
Appleton,
Wisconsin
| – | -$19 | -20 | Closed |
|
156
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$23 | +25 | +10% |
|
CLOV Hedge Fund Activity: Q1 2024 in Review
137 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q1 2024, worth a combined $71.1M — down 23% from $92.7M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of CLOV and 15 opened new positions — a net loss of 5 holders — while 35 trimmed existing stakes and 39 added.
The largest buyer was BlackRock, adding an estimated $1.81M. The largest seller was Vanguard Group, cutting an estimated $6.04M.
- 137 institutional investors held Clover Health Investments (CLOV) as of Q1 2024, down from 144 in Q4 2023.
- Funds reported $71.1M of Clover Health Investments stock for Q1 2024, down 23% quarter-over-quarter.
- 15 funds opened new Clover Health Investments positions in Q1 2024 and 20 closed out, a net change of -5 holders.
- The largest Clover Health Investments buyer in Q1 2024 was BlackRock, an estimated $1.81M added.
- The largest Clover Health Investments seller in Q1 2024 was Vanguard Group, an estimated $6.04M sold.
Based on aggregated 13F filings for Q1 2024.